Processa Pharmaceuticals Executive Lin Acquires Additional Shares Amid Low Valuation Signals
Patrick Lin, serving as the Chief Business - Strategy Officer at Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), executed a stock purchase on June 15, 2026, acquiring 1,831 shares at $2.22 per share, totaling $4,064. This transaction occurs as the stock trades at $2.09, near its 52-week low of $1.76, though shares have gained 5.6% over the past week.…